23 C
New York
Thursday, July 10, 2025

Tag: closing price

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 32,350 shares of the Company’s common stock to two new employees (the “Inducement Grants”) on July 2, 2025 (the “Grant Date”). The Inducement Grants have been granted pursuant to the Company’s 2023 Inducement Plan (the “Plan”). The Inducement Grants were granted as an inducement material to these individuals entering into employment with 89bio in accordance with Nasdaq Listing Rule 5635(c)(4).

MacKenzie Realty Capital Announces Plans for a 1-for-10 Reverse Stock Split

MacKenzie Realty Capital Announces Plans for a 1-for-10 Reverse Stock Split

CYMAT ANNOUNCES ACTIVATION OF ACCELERATED WARRANT EXPIRY DATE

MISSISSAUGA, ON, July 9, 2025 /PRNewswire/ - Cymat Technologies Ltd. (TSXV: CYM) (OTCQB: CYMHF) (the "Company" or "Cymat") is announcing that it is activating...

CYMAT ANNOUNCES ACTIVATION OF ACCELERATED WARRANT EXPIRY DATE

MISSISSAUGA, ON, July 9, 2025 /CNW/ - Cymat Technologies Ltd. (TSXV: CYM) (OTCQB: CYMHF) (the "Company" or "Cymat") is announcing that it is activating...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsClosing price